2026-03-05 14:17 |
Detailed record - Similar records
|
2026-03-05 14:14 |
[DKFZ-2026-00520]
Journal Article
Huaroc Moquillaza, E. ; Steinhelfer, L. ; Weiss, K. ; et al
Clinical feasibility of accelerated whole liver water T1 mapping with T2*-compensation.
Current liver T1 mapping methods present restricted liver coverage, take long acquisition times and mostly exclude the T1 bias induced by fat and iron effects. We evaluated the clinical feasibility of an accelerated water T1 (wT1) mapping method, including all liver segments and the potential of its T2*-compensation (wT1comp) for fibrosis tissue assessment.Forty-three patients were classified into three groups: benign without/with risk of developing fibrosis and hepatocellular carcinoma (HCC). [...]
Detailed record - Similar records
|
2026-03-05 14:12 |
Detailed record - Similar records
|
2026-03-05 14:08 |
Detailed record - Similar records
|
2026-03-05 14:06 |
Detailed record - Similar records
|
2026-03-05 14:05 |
Detailed record - Similar records
|
2026-03-05 14:03 |
[DKFZ-2026-00515]
Journal Article
Cidre-Aranaz, F. ; Geyer, F. H. ; Hölting, T. ; et al
cIAP1 inhibitor of apoptosis is a tumor suppressor in Ewing sarcoma.
Ewing sarcoma (EwS) is a highly aggressive pediatric malignancy driven by EWSR1::ETS fusion oncoproteins -primarily EWSR1::FLI1- which deregulate genes essential for differentiation, proliferation, and cell survival. To uncover key downstream targets of this fusion involved in cell differentiation, we combined transcriptomic profiling of EwS cell lines following EWSR1::FLI1 inhibition with gene ontology analysis, a clinically annotated gene expression dataset derived from EwS patient material and network analyses. [...]
Detailed record - Similar records
|
2026-03-04 14:23 |
Detailed record - Similar records
|
2026-03-04 14:19 |
Detailed record - Similar records
|
2026-03-04 14:16 |
Detailed record - Similar records
|
|
|